Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 2, 2008, Pages 735-742

  Al Zoubi, Nizar ^a   AlKhatib, Hatim S ^b   Bustanji, Yasser ^b   Aiedeh, Khaled ^b   Malamataris, Stavros ^c  

^a APPLIED SCIENCE PRIVATE UNIVERSITY   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Aqueous polymeric dispersions; Buspirone HCl; Eudragit RS 30 D; Kollicoat SR 30 D; Spray drying; Sustained release

Indexed keywords

BUSPIRONE; DODECYL SULFATE SODIUM; EUDRAGIT; KOLLICOAT; POLYMER; POLYVINYL ACETATE; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; DRUG SOLUBILITY; ENCAPSULATION; INFRARED SPECTROSCOPY; MORPHOLOGY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; SUSTAINED DRUG RELEASE; TABLET COMPRESSION;

BUSPIRONE; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; DESICCATION; DRUG COMPOUNDING; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; POLYMETHACRYLIC ACIDS; POLYVINYLS; SEROTONIN AGONISTS; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; WATER;

EID: 43249102092     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.01.002     Document Type: Article

References (24)

1. Hogan J.E. Solvent versus aqueous film coating. Int. J. pharm. Tech. Prod. Mfr. 3 (1982) 7-20
2. Takeuchi H., Handa T., and Kawashima Y. Controlled release theophylline tablet with acrylic polymers prepared by spray drying technique in aqueous systems. Drug Dev. Ind. Pharm. 15 (1989) 1999-2016
3. McGinity J.W. Preface. In: McGinity J.W. (Ed). Aqueous Polymeric Coating for Pharmaceutical Dosage Forms (1997), Marcel Dekker, Inc., New York
4. Wheatley T., and Steuernagel C. Latex emulsions for controlled drug delivery. In: McGinity J.W. (Ed). Aqueous Polymeric Coating for Pharmaceutical Dosage Forms (1997), Marcel Dekker, Inc., New York 1-54
5. Radtke G., Knop K., and Lippold B.C. Manufacture of slow-release matrix granules by wet granulation with an aqueous dispersion of quaternary poly(meth)acrylates in the fluidized bed. Drug Dev. Ind. Pharm. 28 10 (2002) 1295-1302
6. Radtke G., Knop K., and Lippold B.C. Important parameters for the manufacture of slow-release matrix pellets with an aqueous dispersion of quaternary poly(meth)acrylates in the rotary fluidized bed. Drug Dev. Ind. Pharm. 32 3 (2006) 287-296
7. Guo X., and Bodmeier R. Polymeric microparticles prepared by spray-drying a drug-containing aqueous colloidal acrylic polymer dispersion, Eudragit RS 30 D. S.T.P Pharma. Sci. 7 (1997) 521-528
8. Hegazy N., Demirel M., and Yazan Y. Preparation and in vitro evaluation of pyridostigmine bromide microparticles. Int. J. Pharm. 242 (2002) 171-174
9. Broadhead J., Edmond Rouan S.K., and Rhodes C.T. The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 18 (1992) 1169-1206
10. Lehmann K. Chemistry and application of polymethacrylate coating systems. In: McGinity J.W. (Ed). Aqueous Polymeric Coating for Pharmaceutical Dosage Forms (1997), Marcel Dekker, Inc., New York 101-176
11. Wang F.J., and Wang C.H. Effects of fabrication conditions on the characteristics of etanidazole spray-dried microspheres. J. Microencapsul. 19 4 (2002) 495-510
12. Sheikhzadeh M., Rohani S., Jutan A., Manifar T., Murthy K., and Horne S. Solid-state characterization of buspirone hydrochloride polymorphs. Pharm. Res. 23 5 (2006) 1043-1050
13. Sheikhzadeh M., Rohani S., Jutan A., and Manifar T. Quantitative and molecular analysis of buspirone hydrochloride polymorphs. J. Pharm. Sci. 96 (2007) 569-583
14. Sheikhzadeh M., Rohani S., Taffish M., and Murad S. Solubility analysis of buspirone hydrochloride polymorphs: measurements and prediction. Int. J. Pharm. 338 (2007) 55-63
15. R.J. Behme, T.T. Kensler, D.G. Mikolasek, Process for buspirone hydrochloride polymorphic crystalline form conversion, USA Patent, 4, 810, 789 (1989).
16. Sakr A., and Andheria M. Pharmacokinetics of buspirone extended release tablets: a single dose study. J. Clin. Pharmacol. 41 (2001) 1-7
17. Sakr A., and Andheria M. A comparative multidose pharmacokinetic study of buspirone extended release tablets with a reference immediate release product. J. Clin. Pharmacol. 41 (2001) 886-894
18. Takka S., Sakr A., and Goldberg A. Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. J. Control. Release 88 (2003) 147-157
19. Aiedeh K.M., Al-Khatib H., Taha M.O., and Al-Zoubi N. Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug. Die Pharmazie 61 (2006) 306-311
20. Bodmeier R., Guo X., Sarabia R., and Skultery P. The influence of buffer species and strength on diltiazem HCl release from beads coated with the aqueous cationic polymer dispersions Eudragit RS, RL 30D. Pharm. Res. 13 (1996) 52-56
21. Knop K. Influence of buffer composition on drug release from pellets coated with neutral and quaternary acrylic polymers and on swelling of free polymer films. Eur. J. Pharm. Sci. 4 (1996) 293-300
22. D'Souza S., and DeLuca P. Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech 6 2 (2005) E323-E328
23. Giunchedi P., Gavini E., Bonacucina G., and Palmieri G.F. Tabletted polylactide microspheres prepared by a w/o emulsion-spray-drying method. J. microencapsul. 17 (2000) 711-720
24. Kristmundsdóttir T., Gudmundsson O.S., and Ingvarsdóttir K. Release of diltiazem from Eudragit microparticles prepared by spray-drying. Int. J. Pharm. 137 (1996) 159-165